Metastatic HR+/HER2− Breast Cancer With Co-Existing ESR1 and PIK3CA Mutation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Elsevier has made the difficult decision to close PracticeUpdate permanently. There will be no new content published, effective immediately. Although we are all disappointed by this news, we are incredibly grateful for your engagement and support over the years.
We thank the Editorial Boards, Advisory Boards, and Editorial Contributors for their many years of dedication to educating the healthcare community. Our appreciation extends to the many contributors who have shared their valuable time and expertise to help us parse the latest research over the years.
We encourage you to explore our other offerings such as ScienceDirect and ClinicalKey, which continue to provide valuable insights and information to help you excel in your practice.
If you have any questions or need assistance, please see the FAQs section or contact the support team. Thank you for being a part of the PracticeUpdate community!
Only registered members have full access to PracticeUpdate content.
nguyen nguyen
Aug 24, 2023
FAZEL ELAHI
Aug 25, 2023
Susan Sadighi
Aug 25, 2023
Milka Gonzalez
Aug 25, 2023
nagib khoury
Aug 26, 2023
Silvia Falcon
Aug 28, 2023
pramod kumar julka
Aug 28, 2023
FAZEL ELAHI
Sep 09, 2023
Jan 17, 2025
Pending Moderator approval.